Workshop: New Access Opportunities for IBD Patients – Role of Biosimilars
Dear Colleagues,
In the context of IBD being a complex chronic inflammatory disease requiring long-term, individualized treatment strategies, the workshop focuses on discussing the role of biologics and biosimilars based on international guidelines and clinical research data. Aiming to update and exchange current scientific evidence in the management of Inflammatory Bowel Disease (IBD)
NEW ACCESS OPPORTUNITIES FOR IBD PATIENTS:
ROLE OF BIOSIMILARS
Through in-depth reports and academic discussions, the program aims to support healthcare staff in enhancing decision‑making capacity, optimizing effectiveness and safety in clinical practice, thereby contributing to improving the quality of care for patients with inflammatory bowel disease in Vietnam.
If technical support is needed, dear colleagues please contact Pham Dinh Nguyen:
- Phone 028 39525126
- email: khoahocdaotao5@umc.edu.vn.
Sincerely announced.
SCIENTIFIC AND TRAINING DEPARTMENT
UNIVERSITY OF MEDICINE AND PHARMACY HOSPITAL, HCMC
PGS TS BS. Bùi Hữu Hoàng
ThS BS. Đặng Minh Luân
PGS TS DS. Đặng Nguyễn Đoan Trang
Chủ tọa
Báo cáo viên Tham luận viên
PGS TS DS. Đặng Nguyễn Đoan Trang
Please screenshot the successful transfer and send to email: khoahocdaotao5@umc.edu.vn
Time
05/16/2026
Location
In-person venue: Hall 3A (3rd Floor - Area A) University of Medicine and Pharmacy Hospital, Ho Chi Minh City (215 Hong Bang, Cho Lon Ward, Ho Chi Minh City).
Online
Học trực tuyến qua Zoom ID: 828 9051 4278
Participation Fee
Attendance: Free Attendance with certificate issuance 300,000 VND / Participant